Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
54,634,240
-
Share change
-
+8,304,186
-
Total reported value
-
$2,216,609,714
-
Price per share
-
$40.57
-
Number of holders
-
174
-
Value change
-
+$337,125,539
-
Number of buys
-
91
-
Number of sells
-
77
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2017
As of 31 Mar 2017,
HAEMONETICS CORP - Common Stock (HAE) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,634,240 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, VICTORY CAPITAL MANAGEMENT INC, FULLER & THALER ASSET MANAGEMENT, INC., Neuberger Berman Group LLC, DIMENSIONAL FUND ADVISORS LP, and HealthCor Management, L.P..
This page lists
174
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.